Showing results (81-90 of 85) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
The Lancet. Oncology|December 1, 2015
Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trialTsutomu Takashima, Hirofumi Mukai, Fumikata Hara, et al.The Tokai Journal of Experimental and Clinical Medicine|April 9, 2013
Anemia affects the quality of life of Japanese cancer patientsIzumi Wasada, Hisae Eguchi, Maya Kurita, et al.Plos One|January 10, 2019
A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patientsTakanori Watanabe, Hiroshi Yagata, Mitsue Saito, et al.Eclinicalmedicine|August 7, 2024
Eribulin versus S-1 as first or second-line chemotherapy to assess health-related quality of life and overall survival in HER2-negative metastatic breast cancer (RESQ study): a non-inferiority, randomised, controlled, open-label, phase 3 trialMasato Takahashi, Yuichiro Kikawa, Kosuke Kashiwabara, et al.Japanese Journal of Clinical Oncology|February 23, 2025
Multicenter, open-label, randomized, controlled study to test the utility of electronic patient-reported outcome monitoring in patients with unresectable advanced cancers or metastatic/recurrent solid tumorsNaruto Taira, Naomi Kiyota, Yuichiro Kikawa, et al.Pageof 9